心血管保健中的人工智能-第二部分:应用:JACC审查本周的主题
Sneha S Jain1, Pierre Elias2, Timothy Poterucha3
1Division of Cardiology, Stanford University School of Medicine, Palo Alto, California, USA.
Journal of the American College of Cardiology
|April 9, 2024
概括
人工智能 (AI) 正在通过许多FDA批准的算法改变心血管护理. 本综述探讨了人工智能的进步,多式联络输入,生成性人工智能以及在心脏病学中有效实施的基本考虑.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
- 人工智能的人工智能
背景情况:
- 美国食品和药物管理局批准的600多个临床AI算法存在.
- 大约10%的这些算法专注于心血管应用,这表明了显著的增长.
- 人工智能为改善心血管诊断,治疗和患者治疗结果提供了机会.
研究的目的:
- 在心血管护理中审查人工智能的最新进展.
- 专注于使用多式联网输入和生成人工智能.
- 讨论人工智能增强型心血管护理的更广泛背景,包括评估,基础设施,伦理和监管.
主要方法:
- 对心血管应用人工智能的最新进展进行文献综述.
- 对人工智能利用的分析,重点关注多式联网输入和生成性人工智能.
- 讨论实施因素:评估,基础设施,道德,公平,监管和商业模式.
主要成果:
- 人工智能在心血管保健中越来越普遍,FDA的批准越来越多.
- 多模式输入和生成AI代表了进步的关键领域.
- 成功的AI整合需要仔细考虑基础设施,伦理和监管框架.
结论:
- 人工智能具有显著的潜力,可以增强心血管保健,改善诊断,治疗和结果.
- 以患者为中心的实施,严格的评估和道德考虑对于有效利用人工智能至关重要.
- 心脏病学必须采用人工智能,同时保持对患者护理和提供者经验的高标准.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
144
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
144


